Manchester Science Parks tenant, Phagenesis, developer of technology for the treatment of stroke patients, has taken larger office space at MSP's Oxford Road site due to growth.
The company, which span out of Manchester University, recently raised £2m towards the development of a device that delivers electrical pulses to the throat that can "awaken" the brain to help restore swallowing function in stroke victims.
As a result, the business has grown from two to six staff members and moved from a small office in the MedTECH Centre to a 1,428 sq ft office in Enterprise House. The company plans to grow the team by at least two more staff by the end of 2011.
Daniel Green, chief executive of Phagenesis, said: "Our rapid growth and continued support from investors is testament to the quality of the research behind this device and the high calibre team we have in place.
"Being unable to swallow safely is a life-threatening condition. Our technology is the first to have been proven to work in well-controlled clinical trials, and we are now planning product launches."